Sepracor-Looks very promising Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: BMcV who wrote (3583)	8/11/1999 2:27:00 PM
From: j_fir2	Read Replies (1) of 10280

OT Bruce-- For a little leper of a drug (s0 sorry), those sales sure look spectacular! What a ramp up! And the sales aren't even for an optically pure version, just for a new indication. I haven't looked at the financials but I gather this is a story of a true biotech doing (very?) well. That's good to see. I seem to recall Celgene was strongly recommended by the Medical Technology Newsletter back in '95 when I first started looking into this area. Thanks for that. You know, I thought of another advantage to being SEPR. The more companies that bring single isomer versions of parent drugs through trials and to market (like CELG & Ritalin II) the stronger the public awareness of and acceptance of SEPR's story. It's like lots of baby PR firms working for SEPR! (for free!) best wishes, J'fir

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next